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Abstract
Background/Aims: Ocular surface health depends on conjunctival epithelial (HCjE) layer 
integrity since it protects against pathogenic infiltration and contributes to tissue hydration 
maintenance. As the same increases in tear film hyperosmolarity described in dry eye disease 
can increase corneal epithelial transient receptor potential vanilloid type-1 (TRPV1) channel 
activity, we evaluated its involvement in mediating an osmoprotective effect by L-carnitine 
against such stress. Methods: Using siRNA gene silencing, Ca2+ imaging, planar patch-
clamping and relative cell volume measurements, we determined if the protective effects of 
this osmolyte stem from its interaction with TRPV1. Results: TRPV1 activation by capsaicin 
(CAP) and an increase in osmolarity to ≈ 450 mOsM both induced increases in Ca2+ levels. 
In contrast, blocking TRPV1 activation with capsazepine (CPZ) fully reversed this response. 
Similarly, L-carnitine (1 mM) also reduced underlying whole-cell currents. In calcein-AM 
loaded cells, hypertonic-induced relative cell volume shrinkage was fully blocked during 
exposure to L-carnitine. On the other hand, in TRPV1 gene-silenced cells, this protective effect 
by L-carnitine was obviated. Conclusion: The described L-carnitine osmoprotective effect is 
elicited through suppression of hypertonic-induced TRPV1 activation leading to increases in 
L-carnitine uptake through a described Na+-dependent L-carnitine transporter. 
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Department of Ophthalmology, Augustenburger Platz 1, 13353 Berlin (Germany) 
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 IntroductionThe conjunctival epithelial layer is essential for normal vision since its tight junctions 
are protected against pathogenic infiltration and are needed for this tissue to elicit sufficient 
osmotic-driven fluid flow to prevent desiccation of the ocular surface. Such regulation by 
this tissue contributes to maintaining normal tear film osmolarity and isotonic cell volume, 
which sustains close cell-to-cell apposition. However, functional conjunctival tissue activity 
is compromised by tear film hyperosmolarity described in some types of dry eye disease. 
This effect can contribute to the symptomology accompanying this disease. This realization 
of the importance of maintaining intracellular volume isotonicity with the external milieu 
to treat dry eye disease prompted efforts to identify osmolytes that could be of therapeutic value in countering presumed declines in corneal and conjunctival cell volume occurring 
in some types of dry eye disease. One of the organic osmolytes evaluated in dry eye mouse 
models, which improves ocular surface hydration is L-carnitine [1]. Its effectiveness stems 
from the fact that it is taken up into the cell interior by a Na+ coupled co-transporter during 
exposure to a hypertonic stress and contributes to equilibrating the intracellular milieu 
with the external environment [2]. However, the identity of the epithelial hypertonic sensor 
activating the net uptake of L-carnitine during exposure is unknown. 
In human conjunctival epithelial cells (HCjE), one of the transient receptor potential 
(TRP) channels in the 28 member TRP superfamily that is activated by an increase in 
osmolarity was identified by us. This subtype is TRPV1 (capsaicin receptor) [3]. Our 
evidence for functional TRPV1 expression in human conjunctival and corneal epithelial cells 
(HCjE and HCEC, respectively) includes showing that a selective TRPV1 agonist capsaicin 
(CAP) induces Ca2+ transients and underlying whole-cell currents that are eliminated by 
exposure to a TRPV1 antagonist, capsazepine [4]. Such expression is also evident in human 
corneal epithelial cells (HCEC) since exposure to a hypertonic stress elicits TRPV1 activation 
leading to increases in proinflammatory cytokine release via mitogen-activated protein 
(MAP) kinase and NF-κB signaling [5]. It has been suggested that TRPV1 may be a potential 
drug target to reduce dry eye symptomology since this receptor can be stimulated during 
exposure to the same hypertonic conditions identified in tear samples obtained from dry 
eye patients [6]. This consideration prompted us to hypothesize that the osmoprotective 
effects of L-carnitine against hypertonic-induced cell volume shrinkage are elicited through 
an interaction of this osmolyte with TRPV1 in a HCjE immortalized cell line (IOBA-NHC). 
We describe here changes in intracellular Ca2+ regulation and whole-cell currents in 
IOBA-NHC cells induced by L-carnitine in the presence and absence of CAP. The association 
between these changes and the inhibitory effects of L-carnitine on hypertonic-induced 
cell volume shrinkage in the presence of functional TRPV1 expression suggest that its 
osmoprotective effect stems from its interaction with TRPV1. TRPV1 inhibition by carnitine 
appears to contribute to activation of a described Na+ dependent L-carnitine transporter in 
this tissue during exposure to such a challenge since this osmolyte reversed CAP- as well 
as hypertonic-induced increases in [Ca2+]i and also reduced CAP elicited rises in underlying 
whole-cell currents [2]. 
Materials and Methods
Cell Culture
The IOBA-NHC cell line was established through immortalization of normal human conjunctival 
epithelial cells and was kindly provided by Yolanda Diebold's lab. Cells were cultivated as previously 
described [7]. In brief, IOBA-NHC cells were grown in Dulbecco modified Eagle medium DMEM/HAMs F12 
1:1 supplemented with 10% fetal calf serum (FCS), 1 μg/ml insulin, 5 μg/ml hydrocortisone and 100 IU/ml 
penicillin/streptomycin in a humidified 5% CO
2
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RNA isolation and reverse transcriptase polymerase chain reaction (RT-PCR)
Total RNA was extracted from IOBA-NHC cells using TRIzol® Reagent RT (Ambion, Austin, TX). The 
isolated RNA (2 μg) was transcribed into cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems, Darmstadt, Germany). For reverse transcription PCR, 2 µl cDNA mixture was used as template 
in subsequent amplification reactions in a 30 µl total volume containing specific primers for TRPV1 (fwd 
CTCTGGTGGCTAGCCTGTCCTGACA; rev TGGGATCCCGGAGCTTCTCA) generating 285 bp and glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) as template control (fwd TCAACGACCACTTTGTCAAGCTCA; rev 
GCTGGTGGTCCAGGGGTCTTACT) generating a 119 bp product. Each reaction also contained red PCR Master 
Mix (Srtatec, Germany). PCR reaction underwent an initial cycle at 95 °C for 5 min followed by 35 cycles at 
95 °C for 15 s, Primer specific annealing temperatures used were: a) TRPV1 58 °C, b) GAPDH 60 °C for 30 s, 
followed by 72 °C for 45 s, and elongation at 72 °C for 7 min and finally temperature holding at 4 °C. Eight 
microliters of a PCR product were loaded on a 1.5 % agarose gel and after electrophoresis it was visualized 
via ethidium bromide staining under UV light. 
Quantitative real-time PCR
Real-time PCR was performed with Mx 3000P qPCR System real-time cycler (Stratagene, 
Waldbronn, Germany) using specific primers for TRPV1 (fwd TCGCCCTCATGGGTGAGACTGT, rev 
CACCTGCAGCAGCTTGCCTGA) generating a 149 bp product and LightCycler® 480 SYBR Green I Master 
(Roche, Germany) for detection. Amplification was carried out for 45 cycles of 15 s (95°C), 30 s (60°C) and 
was followed by TBE-buffered gel electrophoresis in a 1% agarose gel. Mean CT values were calculated and 
for the relative quantification (RQ), the “relative” expression values were calculated from the delta delta CT 
values. For the normalization, the housekeeping gene GAPDH served as an internal control. 
Western blot
After adding RIPA buffer (50 mMol Tris–HCl, pH 8.0 with 150 mM NaCl, 1.0% NP-40, 0.5% sodium 




) supplemented with protease inhibitor cocktail 
(Roche Diagnostics, Penzberg Germany) to the IOBA-NHC cells, they were scraped and incubated on ice 
for 10 min. Lysates were obtained by centrifugation at 14,000×g for 15 min at 4°C. Protein concentration 
was determined by BCA Protein Assay Kit (Thermo Scientific, Rockford, IL, USA). Briefly, proteins were 
isolated in a RIPA containing buffer.. Twenty five μg of protein were loaded, resolved on 12% Tris–HCl 
SDS-PAGE gel and blotted onto a nitrocellulose membrane (Amersham Biosciences, Freiburg, Germany). 
Membranes were blocked for 1 h using 5% bovine serum albumin at room temperature and incubated with 
primary rabbit polyclonal TRPV1 antibody (Alomone Labs, Jerusalem, Israel) diluted 1: 1000, at 4°C for 
16 h. After washing, the membranes with PBS-T (3x 15 min), they were incubated with HRP-conjugated 
anti-rabbit secondary antibody (Dako, Hamburg, Germany) diluted 1: 5000 for 1 h at room temperature. 
Immunobound antibody was visualized with an enhanced chemiluminescence kit (GE Healthcare Europe, 
Freiburg, Germany). ChemiDoc MP Imaging System (BioRad) was used for chemiluminescence detection. 
For the loading control, membranes were incubated with antibody against ß-actin (Sigma Aldrich) diluted 
1: 10000 for approximately 16 h at 4°C.
Immunocytochemistry
Cells seeded on glass coverslips were cultured at 37°C in a humidified 5% CO
2
 incubator until they were 
50 - 70% confluent. After washing the cells twice with PBS, they were fixed with 4% (w/v) paraformaldehyde 
in PBS for 20 min. Cells were rinsed twice with PBS and then rendered permeable using 0.1% Triton X-100 
solution. After blocking with 10% BSA, cells were incubated overnight at 4°C with primary rabbit polyclonal 
TRPV1 antibody. Cells were twice washed with PBS and exposed to anti-rabbit secondary antibody for 1 h 
and mounted with DAPI for 5 min. Fluorescence was visualized with a Zeiss inverted microscope. 
TRPV1 siRNA transfection 
ON-TARGETplus SMART pool of four individual candidate TRPV1 siRNAs 1#: GGAGACUAUUUCCGAGUUA, 
2#: UGACGAGCAUGUACAAUGA, 3#: CAUCUAUGCCGUCAUGAUA, 4#: CCCGAUAGCUCCUACAACA and non-
targeting siRNA were obtained from Thermo Scientific Dharmacon (Waltham, MA, USA). Fast-Forward 
transfection with 50 nM non-targeting siRNA or 50 nM TRPV1 siRNA was performed using HiPerfect reagent 
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performed for detection of TRPV1 protein expression. The most effective incubation time for obtaining 
maximal suppression of TRPV1 protein expression was 48 h. 
Fluorescence [Ca2+]i measurement 
Time dependent changes in cytosolic free [Ca2+]i were monitored by measuring fura-2 fluorescence. 
Cells were preincubated in a culture medium containing 1 μM fura-2/AM for 30 min at 37°C. Thereafter, 





, 10 mM HEPES acid and 10 mM glucose (pH~7.4) (osmolarity ≈ 300 mOsM). Fluorescence 
measurements were performed at room temperature on the stage of an inverted microscope (Olympus 
BW50WI) with a digital imaging system (TILL Photonics, Munich, Germany). For evaluation, TIDA software 
was used (HEKA electronics, Lamprecht, Germany). Fura-2 fluorescence was alternately excited at 340 and 
380 nm wavelength and emission was detected every 500 ms at 510 nm. The measuring field contained a 




) is a relative index of changes in [Ca2+]i [8]. 




 ± SEM with n values indicating the number of experiments per data point. 
The measurements lasted between 8 to 10 min depending on the experimental design. 
Planar patch-clamp recordings
The semi-automated planar patch-clamp technique in conjunction with an EPC10 amplifier and the 
acquisition software PatchMaster (HEKA, Lambrecht, Germany) as well as the PatchControl software (Nanion, 
Munich, Germany) were used to obtain and evaluate electrophysiological recordings [9]. The resistance of 
the chips corresponded to those of a patch-pipette with a resistance of 3-5 MΩ. For recording, first of all, 5 
µl of an internal-like solution contained in mM: 50 CsCl, 10 NaCl, 2 MgCl
2
, 60 CsF, 20 EGTA and 10 HEPES 
(pH 7.2; osmolarity ≈ 288 mOsM) was applied to the microchip. Cs in the internal solution blocks potassium 
channel outward currents, and the fluoride hydrate-covering suppresses possible anion chloride channels. 
Thereafter, a single cell suspension was prepared in external solution whose composition was (in mM): 




F, 5 D-glucose monohydrate and 10 HEPES (pH ≈ 7.4; osmolarity ≈ 298 
mOsM). Suction was applied automatically by a software controlled pump in order to move a single cell 
on to the aperture of the microchip. Additional suction pulses were used to break open the cell membrane 
establishing the whole-cell configuration. The holding potential (HP) was set to 0 mV to eliminate any 
possible contributions by voltage-dependent Ca2+ or Na+ channel activity. Whole-cell currents were recorded 
using a step protocol involving voltage steps of 10 mV ranging between -60 to +130 mV for 400 ms. Voltage 
changes without steps (voltage ramp) were also used. Membrane capacitance and access resistance 
were calculated with Patchmaster software. A mean access resistance R
S
 of 61 ± 13 MΩ (n = 8) and a 
mean membrane capacitance C
M
 of 8 ± 1 pF (n = 8) were observed in the whole-cell configuration. Series 
resistance errors as well as fast and slow capacity transients were compensated by the software controlled 
patch-clamp amplifier. Cells with leak currents above 100 pA were discarded and current recordings were 
leak-subtracted. All plots were generated with SigmaPlot software version12.3 (Systat, San Jose, California, 
U.S.A.) and an electrophysiology module (Systat, Bruxton). 
Relative cell volume measurements
Relative cell volume was evaluated in a fluorescence microplate analyzer. IOBA-NHC cells were plated 
in a black 96-well culture plate and grown to 80 to 90% confluence. After washing the cells twice with PBS, 
they were loaded with the volume-sensitive fluorescence dye 50 µg calcein/AM dissolved in 25 µl DMSO 
(Invitrogen, Karlsruhe, Germany) whose stock concentration was 2 mM. IOBA-NHC cells were incubated 
for 1 h with 1 µM calcein/AM and then washed again twice with PBS and incubated at room temperature 
with isotonic Ringer-like solution containing L-carnitine for 30 min. Relative cell volume measurements 
were performed using a VICTOR™ X Multilabel Plate Reader (Htds, Paris, France). Calcein fluorescence was 
excited at 485 nm and emission was detected at 530 nm with an integrated photometry system. Bleaching 
was minimized by exciting calcein every 30 s. A 5 min isotonic baseline was recorded each time prior to 
a hypertonic challenge. Before each experiment, fluorescence intensity was monitored under isotonic 
conditions and used for the calculation of drift correction. 
Data analyses and statistics
Parametric paired Student’s t-test was used and in case of too much variance; unpaired t-test with 
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nonparametric Wilcoxon rank sum test was used. Statistical analysis was performed with GraphPad Prism 
(GraphPad software Inc, (La Jolla, CA, U.S.A.) and SigmaPlot software and the values are reported as means 
± SEM. 
Results
TRPV1 gene and protein expression in human conjunctival epithelial (HCjE) cells
TRPV1 gene expression (285 bp) was identified in IOBA-NHC cells using both RT-PCR 
(Fig. 1A) and quantitative real-time PCR analysis. Interestingly, immunofluorescence staining 
revealed with a previously validated selective anti TRPV1 antibody TRPV1 protein expression 
that it is not plasma membrane delimited, but also found in the cytoplasmic region (Figs. 
Fig. 1. TRPV1 gene and protein expression in IOBA-NHC cells. A: Conventional RT-PCR indicate mRNA signal 
of TRPV1 (285 bp) in HCEC-12 (human corneal endothelial cells), LNCaP (lymph node carcinoma of pros-
tate) and IOBA-NHC (normal human conjunctival). The data were normalized to LNCaP with the positive 
mRNA signal. No template control (NTC) proved no template contamination. B-D: Immunocytochemistry 
shows TRPV1 localization. B: Staining nucleus with DAPI (blue). C: TRPV1 positive cells (red). D: merged. 
Fig. 2. TRPV1 siRNA led to a strongly reduced TRPV1 protein expression and abolished CAP-induced Ca2+ 
increase. A: Western blot showing reduced level of TRPV1 protein expression (100 kDa). ß-actin was used 
as a house keeping gene (42 kDa). A control experiment validating anti TRPV1 antibody selectivity was per-
formed using a TRPV1 expressing tumor cell line as a positive control (data shown in [10]). B: Fluorescence 
Ca2+ imaging data clearly confirmed functional expression of TRPV1 (20 µM CAP; open circles) since CAP did 
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1D-E). Validation is based on the western blot analysis demonstrated in a tumor cell line a 
single band of apparent molecular weight corresponding to TRPV1 [10]. Figure 2A compares 
in equal protein containing aliquots TRPV1 expression in IOBA-NHC cells transfected with 
irrelevant siRNAs and those transfected with relevant siRNAs. As found previously, TRPV1 
expression level declined by 61% in TRPV1 siRNA transfected cells whereas in wildtype cells 
transfected with irrelevant siRNAs the expression level was unchanged from that in the non-transfected counterpart [10]. 
Functional expression of TRPV1
To assess TRPV1 function in HCjE cells, the effects were measured of a relatively selective 
TRPV1 agonist, capsaicin (CAP; 20 µM) on intracellular Ca2+ levels. Figure 3A shows that CAP 




 ratio from 1.205 ± 0.0003 (baseline value, t = 
150 s) to 1.228 ± 0.012 (n = 7; *< 0.05; t = 350 s). After 450 s, this ratio was at the same level 
(1.2291 ± 0.013; n = 7; *< 0.05). Preincubation with the relatively selective TRPV1 channel 
blocker capsazepine (CPZ; 20 µM) negated the rise in [Ca2+]i (Fig. 3B). 
Hyperosmotic challenge elicits TRPV1 activation
Figures 3C and D show the differential effects of exposure to 450 mOsM on [Ca2+]i in 
the presence and absence of 20 µM CPZ. Without CPZ, [Ca2+]i gradually and irreversibly rose 
from 1.200 ± 0.00125 (t = 180 s) to 1.240 ± 0.020 (t = 500 s) (n = 5; * p < 0.05) whereas with 
Fig. 3. Capsaicin (CAP) and hyperosmolarity increased Ca2+ influx in IOBA-NHC cells and capsazepine (CPZ) 
blocks this effect. A: 20 µM CAP induced an irreversible Ca2+ entry (n = 7; filled circles). Without CAP ap-
plication, no changes in Ca2+ influx could be observed (n = 5; open circles). B: 20 µM CPZ suppressed the 
CAP-induced Ca2+ influx (n = 7). C: Hyperosmotic stress (450 mOsM) also increased Ca2+ influx (n = 4; filled 
circles) whereas no Ca2+ entry could be detected without the application of hyperosmotic stress (n = 9; open 
circles). D: 20 µM CPZ suppressed Ca2+ influx induced by hyperosmotic stress (n = 5). Moreover, even a re-
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20 µM CPZ [Ca2+]i it instead declined below the control level to reach 1.186 ± 0.0025 (n = 5; 
**p < 0.01). This effect shows that TRPV1 activation contributes to the rises in [Ca2+]i induced 
by a hyperosmotic challenge (Fig. 3D, 4D). 
Effect of L-carnitine on TRPV1-mediated Ca2+ regulation
The reversal of the rise in [Ca2+]i induced by either CAP or a hypertonic challenge in 
the presence of CPZ suggested TRPV1 involvement in osmotic-induced cell shrinkage. 
As L-carnitine is an osmolyte countering hypertonic-induced corneal and conjunctival 
epithelial shrinkage through its uptake by a Na+ dependent co-transporter, we determined 
if its protective effect involves a change in TRPV1 function [2]. We first evaluated TRPV1 
involvement in eliciting the L-carnitine osmoprotective effect by seeing if the increases in 
[Ca2+]i elicited by either CAP or a 450 mOsM challenge are altered in the presence of 1 mM 
Fig. 4.  L-carnitine inhibits CAP and hyperosmotic stress-induced Ca2+ influx in IOBA-NHC cells. A: 20 µM 
CAP induced Ca2+ entry could be completely suppressed with 1 mM L-carnitine preincubation (filled tri-
angles). Moreover, even a reduction below baseline could be observed. As the negated rise in [Ca2+]i was 
similar as CPZ in the previous set of experiments, it is suggested that L-carnitine may influence the TRPV1-
mediated Ca2+ regulation. B: Similarly, a Ca2+ increase by hypertonic challenge could be completely sup-
pressed with 1 mM L-carnitine preincubation (filled triangles). A reduction below baseline could also be 
observed similar to that shown in Fig. 4A. C: In contrast, no reduction below baseline could be observed if 
cells were preincubated in both 20 µM CPZ and 1 mM L-carnitine. D: Summary of the experiments with CAP, 
CPZ, L-carnitine and hypertonic challenge. The asterisks (*) indicate significant differences (at the minimum 
p < 0.05; unpaired Student’s t-test) between control (Ca2+ base level at 500 s) and 20 µM CAP, 20 µM CPZ, 
1 mM L-carnitine and hypertonic challenge (450 mOsM), respectively (all at 500 s). The hash (#) indicates 
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L-carnitine. Figure 4A shows that preincubation with 1 mM L-carnitine for 15 to 60 min in 
isotonic medium had the same effect as CPZ on the hypertonic challenge; namely, a reversal of the increases in [Ca2+]i induced by 20 µM CAP. Under this condition, baseline [Ca2+]i fell 
from 1.200 ± 0.00056 to 1.191 ± 0.002 (n = 9; * p < 0.05; t = 500 s) (Fig. 4A). As with CAP, a hypertonic challenge also caused [Ca2+]i to decline (Fig. 4B). The fluorescence ratio decreased 
Fig. 5. Effect of CAP and L-carnitine on whole-cell currents. Currents were measured using the planar patch-
clamp technique with leak subtraction. Holding potential was set to 0 mV to avoid influence of voltage de-
pendent Ca2+ and Na+ currents A-B: Whole-cell currents following voltage stimulation from -60 to +130 mV 
in 10 mV steps for 400 ms each. 20 µM CAP increased in- and outward whole-cell channel currents. C: 1 mM 
L-carnitine suppressed both in- and outward currents. D: Effects of CAP and L-carnitine are summarized in 
a current/voltage plot (I/V plot). For the current/voltage relation, maximal peak current amplitudes were 
plotted against the voltage (mV). The upper trace (red filled circles) was obtained in the presence of 20 µM 
CAP and the lower trace (orange filled circles) in the presence of 1 mM L-carnitine. Controls without applica-
tion of drugs had no effect on whole-cell currents (open circles). E: Summary of the experiments with CAP 
and L-carnitine (n = 6). The asterisks (*) indicate statistically significant differences of in- and outward cur-
rents with and without L-carnitine (n = 6; p < 0.05; paired tested). F: Maximal negative current amplitudes 
induced by a voltage step from 0 mV to -60 mV are depicted in percent of control values before application 
of 20 µM CAP. CAP-induced inward currents could be clearly suppressed in the presence of 1 mM L-carnitine. 
G: Maximal positive current amplitudes induced by a voltage step from 0 mV to 130 mV are depicted in per-
cent of control values before application of 20 µM CAP. CAP-induced outwardly rectifying currents could be 



















   
   
   
   
   
   
   
   
   




















Cell Physiol Biochem 2014;34:790-803
DOI: 10.1159/000363043
Published online: August 19, 2014
© 2014 S. Karger AG, Basel
www.karger.com/cpb 798
Khajavi et al.: L-Carnitine Suppresses TRPV1 in HCjE Cells
Cellular Physiology 
and Biochemistry
from 1.201 ± 0.001 (n = 5; t = 180 s) to 1.182 ± 0.003 (t = 500 s) in the presence of L-carnitine 
following hypertonic challenge (n = 5; ** p < 0.01). This equivalence between the inhibitory 
effects of L-carnitine and CPZ on the [Ca2+]i transients induced by CAP and a hypertonic 
challenge suggests that L-carnitine and CPZ elicit [Ca2+]i reversal through interacting 
with TRPV1. These reversal effects by 1 mM L-carnitine supplementation prompted us to 
hypothesize that L-carnitine elicits an osmoprotective effect against a hypertonic challenge 
through inhibition of TRPV1 activation. To test this hypothesis, we preincubated the cells 
with 20 µM CPZ and 1 mM L-carnitine and then exposed them to CAP. Under this condition, 
the results shown in Figure 4C indicate that the decline in [Ca2+]i induced by CAP was less 
than that in the absence of L-carnitine (Fig 3B) suggesting that L-carnitine interaction with 
TRPV1is different than that of this antagonist. 
Effect of L-carnitine on TRPV1-mediated whole-cell currents
To characterize the ionic currents underlying this L-carnitine-induced decline in 
intracellular Ca2+ levels, the planar patch-clamp technique in the whole-cell configuration 
was used (Fig. 5A-E). At -60 mV, CAP strongly increased inward currents from -10 ± 4 pA/
pF to -23 ± 6 pA/pF confirming Ca2+ influx (n = 6; ** p < 0.01). At +130 mV, outwardly 
rectifying currents significantly increased from 48 ± 13 pA/pF to 122 ± 18 pA/pF in the 
presence of CAP (n = 6; * p < 0.05) (Fig. 5A-B). In contrast, in- and outward currents were 
significantly reduced in the presence of 1 mM L-carnitine in the external solution. Inward 
currents corresponding to the Ca2+ influx significantly decreased to -11 ± 3 pA/pF (n = 6; * p 
< 0.05) (Fig. 5C-E). Similarly, outwardly rectifying currents decreased to 80 ± 16 pA/pF (n = 
6; ** p < 0.01) (Fig. 5C-E). In summary, L-carnitine clearly suppressed increases in whole-cell 
currents mediated by TRPV1 activation. 
Effect of L-carnitine on cell volume regulation 
The effects of L-carnitine on relative cell volume were monitored in calcein-AM loaded 
cells under optical conditions in which there is an inverse relationship between relative 
increases in cell volume and fluorescence intensity. Figure 6 A and B compares the effect 
of a hypertonic challenge on the fluorescence intensity in the presence and absence of 1 
mM L-carnitine. To avoid irreversible shrinkage induced by 450 mOsM exposure, which 
prevented restoration of isotonic volume upon re-exposure to isotonic medium, the cells were 
exposed instead to 400 mOsM. This stress caused the signal to decline by ≈ 20% without any 
recovery (Fig 6A, filled circles). This decline is indicative of shrinkage due to dye quenching. 
On the other hand, Fig. 6B shows that during 1 mM L-carnitine exposure, the signal remained 
Fig. 6. L-carnitine suppresses hypertonocity-induced cell shrinkage. A: Hypertonic challenge (400 mOsM) 
led to a reduction of fluorescence signals corresponding to a reduction in the cell volume (filled circles). In 
contrast, isotonic solution (318 mOsM) had no effect (both n = 12; open circles). B: L-carnitine abolished the 
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unchanged suggesting that this osmolyte is internalized to equilibrate extracellular and 
intracellular osmolarity. To assess the involvement of TRPV1 in this osmoregulatory response 
to a hypertonic challenge, we determined whether L-carnitine in TRPV1 gene silenced cells 
affected the decline in fluorescence intensity induced by exposure to a hypertonic challenge. 
Figure 7A (open circles) shows again that in control non transfected TRPV1 expressing cells, 
the hypertonic challenge induced a 20% decline in fluorescence intensity whereas in TRPV1 
gene silenced cells the signal declined instead by 65% (Fig. 7A, filled circles) suggesting a 
much larger cell volume shrinkage. On the other hand, preincubation with 1 mM L-carnitine in 
these gene-silenced cells was reduced to 40% suggesting that partial TRPV1 knockdown (i.e. 
40%) was sufficient to induce partial protection against this challenge. The best protection 
against shrinkage was obtained in non-transfected cells exposed to both CPZ and L-carnitine 
since there was no perceptible shrinkage (Fig. 7C, filled circles). These results suggest that 
the osmosensor function of TRPV1 in eliciting a regulatory volume response depends on its 
inactivation leading to compensatory increases in L-carnitine uptake and equilibration with 
the external milieu. 
Discussion 
L-carnitine is reported to have osmoprotective effects against exposure to hypertonic 
stress in human corneal epithelial cells as well as in retinal pigment epithelial cells [11, 12]. 
However, an interaction was not considered between this osmolyte and TRPV1 in inducing an osmoregulatory response  even though this channel acts as an osmosensor of hypertonic 
stress in numerous other tissues [3]. As there is TRPV1 gene- and protein expression as well 
functional activity in HCjE [7], we determined here if such an interaction exists in IOBA-
NHC cells. We found that L-carnitine suppressed CAP-induced Ca2+ increases and whole-
Fig. 7. L-carnitine effect is associated with TRPV1. A: TRPV1 siRNA treated cells (filled circles) led to a re-
duction of the cell volume at larger levels compared to controls (both n = 12; open circles). B: Same experi-
ment as shown in A, but in cells pre-incubated in 1 mM L-carnitine. This clearly reduced the hypertonicity 
induced reduction in cell volume. C: Hypertonic challenge-induced cell shrinkage with L-carnitine (filled 
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cell currents. Furthermore, such effects of L-carnitine were associated with declines in 
TRPV1 function since hypertonic-induced shrinkage was less pronounced in TRPV1 gene 
silenced cells than in their non-transfected counterpart. A more definitive indication of the 
dependence of the osmoregulatory protective effect on TRPV1 inhibition is that relative cell 
volume was nearly invariant in non-transfected cells during exposure to either L-carnitine 
or CPZ (Fig. 7B and 7C, respectively). 
Carnitine interaction with capsaicin receptor expression 
TRPV1 protein expression was identified in both the plasma membrane and cytoplasmic 
regions. Its plasma membrane localization is consistent with CAP-induced increases in Ca2+ 
influx as well as suppression of this response by CPZ.  Another indication is that in TRPV1 
knockdown cells, CAP-induced Ca2+ influxes could be clearly suppressed despite a decline 
in TRPV1 protein expression of only approx. 60%. However, the functional role of cytosolic 
TRPV1 localization remains unclear. The reversal by L-carnitine of the rise in [Ca2+]i induced 
by CAP and a hypertonic challenge (Fig. 4) suggested that this osmolyte induced a cellular 
osmoregulatory response countering shrinkage through suppressing TRPV1 function. A 
described Na+ dependent: L-carnitine co-transporter in corneal and conjunctival epithelial 
cells is one mediator of L-carnitine’s osmoprotective function [2]. To assess if L-carnitine 
uptake could contribute to osmoprotection against a hypertonic challenge in the presence of 
CPZ, we compared the effects of a hypertonic challenge on [Ca2+]i in the presence and absence 
of L-carnitine. Figure 4 shows that the decline in [Ca2+]i in the presence of L-carnitine was 
comparable to that of CPZ (Fig. 3B, 3D) indicating that intracellular Ca2+ regulation was similar 
during L-carnitine exposure. This suggests that L-carnitine provides an osmoprotective 
function against an intracellular Ca2+ rise induced by a hypertonic challenge. Even though 
there is sufficient evidence indicating that carnitine inhibits TRPV1 activation by either a 
hyperosmolar challenge or CAP, it is not possible to determine if its effect stems from an 
interaction with TRPV1 that is similar with CPZ. Nevertheless, it is possible that the critical 
channel determinants may be different for CPZ and L-carnitine since the declines in Ca2+ 
influx induced by CAP were less in the combined presence of both L-carnitine and CPZ than 
without L-carnitine. The mechanism of suppression of TRPV1 activation by capsazepine 
has been described in earlier studies. Critical molecular determinants located in the 
transmembrane domain between the third and fourth spans are required for capsazepine 
and other antagonists to prevent capsaicin from inducing TRPV1 activation. Our study did 
not employ the needed protocols and techniques to determine if L-carnitine also interacts 
with the same critical determinants described for a number of other structurally diverse 
antagonists [13]. 
L-carnitine and TRPV1 channels
While there are reports describing the effect of L-carnitine on Ca2+ channels in other 
tissues, to the best of our knowledge nothing is yet known about an interaction with TRP-
like whole-cell currents. Some studies focused on voltage-operated Ca2+ channels (L-type) in 
porcine ventricular sarcolemma using palmitoyl-L-carnitine. Whereas at low concentrations 
(1 µM), L-type channel currents increased, they decreased at higher concentrations (10 
µM) [14]. In another study in rat pheochromocytoma (PC12) cells, short-term exposure to 
1 mM acetyl-L-carnitine ester instead decreased the open probability of L-type channels 
corresponding to lower L-type channel activity [15]. In our study, we used L-carnitine at a 
relatively higher concentration of 1 mM, than that in the L-type channel studies, but it was 
10 times lower than that used in a human corneal epithelial cell line [12]. Our results show 
that L-carnitine clearly suppressed CAP-induced whole-cell currents. The properties of the 
CAP-induced currents correspond to those reported in  this cell line [7]. TRPV1-like currents 
have an outwardly rectifying component and a reverse potential of 0 mV, which is indicative 
of non-selective ion channel currents. Notably, the CAP-induced Ca2+ inward currents (Fig. 5) 
are in line with CAP-induced Ca2+ influx. This is attributable to a high Ca2+ concentration in 
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Ca2+ gradient. Under control conditions, there are nearly no inward currents, but only small 
outward currents, which probably are anion channel currents (chloride channels). Activation 
of chloride channels by CAP can be excluded since CAP is selective for TRPV1, which is a 
non-selective cation channel [16]. Therefore, it is suggested that these currents are mainly 
cation channel currents since similar studies in HCEC showed that with CAP increases in 
cation channel currents persisted even though chloride was replaced by gluconate [4]. 
As L-carnitine suppressed both of these currents, these declines stem from an inhibition 
by L-carnitine of TRPV1 function. Overall, the suppression by L-carnitine of CAP-induced 
increases in whole-cell currents are comparable to those elicited by CPZ in non-conjunctival 
epithelial cells [17].
L-carnitine and cell volume regulation
The hyperosmolar induced increases in Ca2+influx mediated by TRPV1 channel activation 
are similar to those described in HCEC [5]. The fact that in the current study these increases 
in Ca2+influx were attenuated by ≈ 65 % in TRPV1 knockdown cells substantiates the notion 
of TRPV1 involvement in inducing a Ca2+ transient. This indicates TRPV1 involvement 
in eliciting osmoregulatory responses to a hypertonic challenge by reducing shrinkage. 
L-carnitine practically blocked shrinkage induced by such a challenge through a presumable 
increase its intracellular uptake by a described L-carnitine Na+ coupled co-transporter. This 
suggestion is consistent with our finding that in a Na+-free medium L-carnitine had less of an 
effect on hypertonic-induced relative cell volume shrinkage (data not shown). 
Potential clinical relevance
Currently, the treatment of dry eye disease is largely palliative since the underlying 
mechanisms of this sight compromising syndrome are not yet fully understood. In some types of dry eye disease arising from either decreases in tear volume secretion or increases 
in tear evaporation, there are reports that the tears are hypertonic [14]. In some cases in 
which there is extensive damage to the ocular surface caused by hypertonic-induced cell 
shrinkage and compromise of epithelial barrier function, tear film osmolarity increases can 
reach levels approaching those used in the current study [18]. Our results extend previous 
studies which showed in evaporative dry eye mouse models  that osmolyte supplementation 
of artificial tears markedly improves ocular surface health by reducing inflammation and 
neovascularisation [1]. One of the osmolytes identified to have this therapeutic effect is 
L-carnitine since its intracellular uptake is stimulated during exposure to a hypertonic 
stress resulting in decreases in dry eye symptomology caused by cell volume shrinkage. The 
current study extends our understanding of the mechanism involved in eliciting activation 
of a described Na+ coupled L-carnitine co-transporter whose activation elicits equilibration 
of the intracellular milieu with the extracellular osmolarity. The results indicate that TRPV1 
by acting as a hypertonic osmosensor appears to elicit increases in L-carnitine uptake to 
reduce shrinkage. Interestingly, its role is dependent on TRPV1 inhibition by L-carnitine 
rather than activation. Taken together, these results suggest that it may be possible in a 
clinical setting to reduce hyperosmotic-induced ocular surface damage by blocking TRPV1 
activation. Development of drugs for such a purpose may, however, be problematic since 
TRPV1 activation subsequent to injury has other functions that are essential to promoting 
wound healing by stimulating epithelial proliferation which is required for rapid closure of 
a wound [19, 20]. 
In summary, L-carnitine has an osmoprotective effect in HCjE cells because of its 
inhibitory effect on TRPV1-mediated Ca2+ signaling eliciting an osmoprotective effect against 
a hypertonic challenge. Studies are still needed to clarify how a decline in TRPV1 activity 
leads to activation of Na+ dependent L-carnitine co-transporters and equilibration of the 
intracellular and extracellular osmolyte levels. A major challenge will be to clarify a possible 



















   
   
   
   
   
   
   
   
   




















Cell Physiol Biochem 2014;34:790-803
DOI: 10.1159/000363043
Published online: August 19, 2014
© 2014 S. Karger AG, Basel
www.karger.com/cpb 802




HCjE (human conjunctival epithelium); TRPV (transient receptor potential vanilloid); 
TRPM (transient receptor potential melastatin); CAP (capsaicin); CPZ (capsazepine); La3+ 
(lanthanum-III-chloride).
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